Vanta Bioscience Ltd IPO (Vanta Bioscience IPO) Detail

Sep 25, 2017 - Sep 27, 2017

Incorporated in 1995, Vanta Bioscience Ltd (VBL) is a preclinical contract research company whhich offers safety assessment services for clientele from Pharmaceutical, Medical Devices, Nutraceuticals, Feed Additive, Biotech, Agrochemicals, Cosmetics, and Chemical industries.

In addition they also provides risk assessment services for evaluating the safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachable including pharmaceutical impurities resulting due to manufacturing process or due to degradation of the product. VBL also provides expert services for determination of health based exposure limits (e.g. permitted daily exposure (PDE) or allowable daily exposure (ADE) including occupational exposure limits (OEL) for pharmaceutical manufacturers. Their services include toxicology, batch release tests, biocompatibility studies, chemical safety, and diet formulation.

One of the major services of VBL is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The relationship between dose and its effects on the exposed organism is of high significance in toxicology. Toxicology and safety assessment are sometimes used interchangeably and considered as synonymous.

Vanta Bioscience based in Des Moines, Iowa with additional offices in Brussels, Belgium; and West Des Moines, Iowa. It has a toxicology research facility in Chennai, India.

Objects of the Issue

The objects of the Net Proceeds of the Issue are:

1. Augmenting additional working capital requirements;
2. General Corporate Purposes.

Vanta Bioscience IPO Details

IPO Date Sep 25, 2017 to Sep 27, 2017
Listing Date Friday, October 6, 2017
Face Value ₹10 per share
Price ₹50 per share
Lot Size 3000 Shares
Issue Size1,512,000 shares of ₹10
(aggregating up to ₹7.56 Cr)
Issue Type Fixed Price Issue IPO
Listing At BSE SME
Company Promoters

The promoters of the company are:

1. Mohan Krishna Mulakala,
2. Dopesh Raja Mulakala,
3. Dr Vyasmurti Madhavrao Shingatgeri,
4. Dr. Soumya Simhadri,
5. Shravan Chintapatla,
6. Karishma Mulakala,
7. Sajan Kiran Mulakala,
8. Pradeep Chowdary and
9. Dr. Chandrasekhar Rao Simhadri

Vanta Bioscience IPO Lot Size

The Vanta Bioscience IPO lot size is 3000 shares. A retail-individual investor can apply for up to 1 lots (3000 shares or ₹150,000).

Application Lots Shares Amount
Retail (Min) 1 3000 ₹150,000
Retail (Max) 1 3000 ₹150,000

Vanta Bioscience IPO Review

Simply avoid this issue as it has no track records. Read detail review...

Vanta Bioscience IPO Subscription Status (Bidding Detail)

The Vanta Bioscience IPO is subscribed times on Sep 27, 2017 5:00:00 PM. The public issue subscribed times in the retail category, times in the QIB category, and times in the NII category. Check Day by Day Subscription Details (Live Status)

CategorySubscription (times)

Vanta Bioscience IPO Prospectus

Vanta Bioscience IPO Rating

Rating:Rated 3.7 stars
Vote Here ...

Vanta Bioscience IPO Listing Date

Listing Date Friday, October 6, 2017
BSE Script Code 540729
NSE Symbol
Listing In M Group of Securities
ISIN INE695X01011
IPO Price ₹50 per share
Face Value ₹10 per share

Listing Day Trading Information

IPO Price
Last Trade

Company Contact Information

Vanta Bioscience Ltd
NO 02/G/308/G, NO 3/FF/SF/1-20-248 Umajay Complex,
Rasoolpura, Secunderabad,
Hyderabad 500 003
Phone: +91 40 6657 5454

Vanta Bioscience IPO Registrar

Bigshare Services Pvt Ltd

Phone: +91-22-6263 8200

Vanta Bioscience IPO Review

Vanta Bioscience IPO Recommendation Summary

Review By Subscribe Neutral Avoid
Brokers 0 0 1
Members 0 0 0

Read All Reviews Post Your Review Manage Reviews

IPO Broker Recommendations

Vanta Bioscience IPO FAQs

Vanta Bioscience IPO is a SME IPO of 1,512,000 equity shares of the face value of ₹10 aggregating up to ₹7.56 Crores. The issue is priced at ₹50 per share. The minimum order quantity is 3000 Shares.

The IPO opens on Sep 25, 2017, and closes on Sep 27, 2017.

Bigshare Services Pvt Ltd is the registrar for the IPO. The shares are proposed to be listed on BSE SME.

The Vanta Bioscience IPO opens on Sep 25, 2017 and closes on Sep 27, 2017.

Vanta Bioscience IPO lot size is 3000 Shares and the minimum order quantity is .

You can apply in Vanta Bioscience IPO online using either UPI or ASBA as payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don't offer banking services. Read more detail about apply IPO online through Zerodha, Upstox, 5Paisa, Edelweiss, ICICI Bank, HDFC Bank and SBI Bank.

The finalization of Basis of Allotment for Vanta Bioscience IPO will be done on [.], and the allotted shares will be credited to your demat account by [.]. Check the Vanta Bioscience IPO allotment status.

The Vanta Bioscience IPO listing date is on Friday, October 6, 2017.
Open an Instant Account with Zerodha

Vanta Bioscience IPO Message Board

Ranked Members of Forum  Ranked Members | Most Liked Members



8. LoneRanger |   Link |Oct 3, 2017 5:08:29 PM
Top Contributor Top Contributor (200+ Posts, 200+ Likes)
Wow, very good response from HNI and QIB.
Hope to list in premium.
8.1. STOCKT |   Link |Oct 4, 2017 1:11:35 AM
lol where is good response. its in fact very low response
7. ConstrainedEPS |   Link |Sep 25, 2017 10:37:39 PM
Why there is no info about P&L ? I mean they just acquired this business by paying 12 Cr without bothering about Balance Sheet ?
and now wants to sell it to public for Valuation of 28 Cr ?
I am not able to understand the valuation here ... They atleast could have just provided the past revenue / profit of the company ?
IPO euphoria h toh kuch bhi beecho bc ,.,,
6. GkRaya |   Link |Sep 14, 2017 7:42:43 PM
It is mentioned that the company is based out of Iowa and Belgium. Company website has Secundarabad and Chennai addresses. Only research center is in Chennai. Is it a foreign based company and entering into Indian market? Regarding GVK, point is already raised in this forum...A clarification requested...
6.1. JS Investor |   Link |Sep 20, 2017 5:15:59 PM
GVK entered into the agreement but deal couldnt go through. Post that these promoters acquired the facility in the new company and were allowed to use name Vanta by erstwhile US Promoters
5. beingshreyas |   Link |Sep 18, 2017 8:34:39 PM
avoid this.
4. GkRaya |   Link |Sep 14, 2017 7:48:37 PM
At the same time, profile is good
3. Rafiq |   Link |Sep 14, 2017 2:43:26 PM
Top Contributor Top Contributor (400+ Posts, 400+ Likes)
In simple words GVK company ne is company ko kharida tha 2014 me to yeh company kaise apna share khud bech sakti hai?
2. NPP |   Link |Sep 14, 2017 12:03:41 PM
Yes ,You are right sir , I have gone through your given Website , When agreement done in 2014 As same your understanding I could not say how this company can sell equity ? If any one help who really guide , Pl help . .......
1. Rafiq |   Link |Sep 14, 2017 1:54:24 AM
Top Contributor Top Contributor (400+ Posts, 400+ Likes)

When GVK bioscience signed definitive agreement, how come this company is selling their shares? Can anyone help me to understand.